Tobacco Company Efforts to Influence the Food and Drug Administration-Commissioned Institute of Medicine Report Clearing the Smoke: An Analysis of Documents Released through Litigation

BACKGROUND: Spurred by the creation of potential modified risk tobacco products, the US Food and Drug Administration (FDA) commissioned the Institute of Medicine (IOM) to assess the science base for tobacco “harm reduction,” leading to the 2001 IOM report Clearing the Smoke. The objective of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Crystal E., Kyriss, Thomas, Glantz, Stanton A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665841/
https://www.ncbi.nlm.nih.gov/pubmed/23723740
http://dx.doi.org/10.1371/journal.pmed.1001450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665841/
https://www.ncbi.nlm.nih.gov/pubmed/23723740
http://dx.doi.org/10.1371/journal.pmed.1001450

Ejemplares similares